All Publications

Resident shown in bold. Research Mentor(s) shown in color.
  1. Iqbal Z, Kim S, Moyer J, Moses W, Abada E, Wright N, Kim EJ, Park J, Fissell WH, Roy S. In vitro and in vivo hemocompatibility assessment of ultrathin sulfobetaine polymer coatings for silicon-based implants. J Biomater Appl. 2019 Mar 12; 885328219831044. View in PubMed
  2. Iqbal Z, Moses W, Kim S, Kim EJ, Fissell WH, Roy S. Sterilization effects on ultrathin film polymer coatings for silicon-based implantable medical devices. J Biomed Mater Res B Appl Biomater. 2018 Aug; 106(6):2327-2336. View in PubMed
  3. Dharia A, Abada E, Feinberg B, Yeager T, Moses W, Park J, Blaha C, Wright N, Padilla B, Roy S. Silicon Micropore-Based Parallel Plate Membrane Oxygenator. Artif Organs. 2018 Feb; 42(2):166-173. View in PubMed
  4. Song S, Blaha C, Moses W, Park J, Wright N, Groszek J, Fissell W, Vartanian S, Posselt AM, Roy S. Correction: An intravascular bioartificial pancreas device (iBAP) with silicon nanopore membranes (SNM) for islet encapsulation under convective mass transport. Lab Chip. 2017 06 27; 17(13):2334. View in PubMed
  5. Song S, Blaha C, Moses W, Park J, Wright N, Groszek J, Fissell W, Vartanian S, Posselt AM, Roy S. An intravascular bioartificial pancreas device (iBAP) with silicon nanopore membranes (SNM) for islet encapsulation under convective mass transport. Lab Chip. 2017 05 16; 17(10):1778-1792. View in PubMed
  6. Padilla BE, Moses W. Lower Gastrointestinal Bleeding & Intussusception. Surg Clin North Am. 2017 Feb; 97(1):173-188. View in PubMed
  7. Jordan EJ, Feldstein VA, Moses W, Phelps AS. Radiologic assessment of fetal tracheal balloon occlusion. Clin Imaging. 2017 Mar - Apr; 42:113-118. View in PubMed
  8. Kim S, Feinberg B, Kant R, Chui B, Goldman K, Park J, Moses W, Blaha C, Iqbal Z, Chow C, Wright N, Fissell WH, Zydney A, Roy S. Diffusive Silicon Nanopore Membranes for Hemodialysis Applications. PLoS One. 2016; 11(7):e0159526. View in PubMed
  9. Mathur A, Moses W, Rahbari R, Khanafshar E, Duh QY, Clark O, Kebebew E. Higher rate of BRAF mutation in papillary thyroid cancer over time: a single-institution study. Cancer. 2011 Oct 01; 117(19):4390-5. View in PubMed
  10. Moses W, Weng J, Kebebew E. Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer. Thyroid. 2011 Apr; 21(4):367-71. View in PubMed
  11. Mathur A, Weng J, Moses W, Steinberg SM, Rahbari R, Rahabari R, Kitano M, Khanafshar E, Ljung BM, Duh QY, Clark OH, Kebebew E. A prospective study evaluating the accuracy of using combined clinical factors and candidate diagnostic markers to refine the accuracy of thyroid fine needle aspiration biopsy. Surgery. 2010 Dec; 148(6):1170-6; discussion 1176-7. View in PubMed
  12. Moses W, Weng J, Sansano I, Peng M, Khanafshar E, Ljung BM, Duh QY, Clark OH, Kebebew E. Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy. World J Surg. 2010 Nov; 34(11):2589-94. View in PubMed
  13. Vriens MR, Moses W, Weng J, Peng M, Griffin A, Bleyer A, Pollock BH, Indelicato DJ, Hwang J, Kebebew E. Clinical and molecular features of papillary thyroid cancer in adolescents and young adults. Cancer. 2011 Jan 15; 117(2):259-67. View in PubMed
  14. Vriens MR, Suh I, Moses W, Kebebew E. Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer. Thyroid. 2009 Dec; 19(12):1343-9. View in PubMed
  15. Moses W, Weng J, Khanafshar E, Duh QY, Clark OH, Kebebew E. Multiple genetic alterations in papillary thyroid cancer are associated with younger age at presentation. J Surg Res. 2010 May 15; 160(2):179-83. View in PubMed
Data provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Willieford Moses, M.D
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.